Loading viewer...
presentation
Format: PDF presentation
This presentation discusses the PRECISION-1 trial evaluating nab-sirolimus for advanced malignancies with TSC1 and TSC2 alterations, highlighting its efficacy and safety.
37 Pages
presentation
Siemens
presentation
Magna International
presentation
Apple
presentation
POINT Biopharma